Pharmaceutical Executive
January 01, 2012
Issue PDF
0
0
Industry Forecast 2012 : Bridging the Divide
January 01, 2012
Features
0
0
Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.
January 01, 2012
0
0
Hungary's high-quality infrsatructure, highly skilled labor force, and central geographic location have turned the country into an attractive destination for investment.
January 01, 2012
0
0
William Looney looks at how Big Pharma is attempting to bridge the emerging markets' widening cancer divide.
January 01, 2012
0
0
The use and study of DDW by the Hungarian medical community
January 01, 2012
Columns
0
0
Look for action in 2012 on drug access, shortages, innovation, and transparency.
January 01, 2012
0
0
A quick chat with CMO of Assign Group Dr. Kata Mazalin
January 01, 2012
Columns
0
0
It's a disturbing irony: In an industry whose entire economic value is founded on its ability to innovate, why is there so much discomfort with the risk required for innovation. Where did the courage to innovate go?
January 01, 2012
Columns
0
0
A selection of the recent breakthrough technologies showcased at the Cleveland Clinic's Medical Innovations Summit.
January 01, 2012
Columns
0
0
A key consideration under the Affordable Care Act is how states select plans for drug coverage.
January 01, 2012
Features
0
0
Mason Tenaglia offers empirical defense of coupons and copay offset programs.
January 01, 2012
Features
0
0
The challenge for 2012 is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
January 01, 2012
Columns
0
0
A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science.
January 01, 2012
0
0
How can pharma embrace and interact with increasingly informed and demanding patients to bring positive outcomes for all?